Hong Kong Pharma Digital Technology (HKPD) said Thursday it closed initial public offering of 1.4 million ordinary shares at $4 each, including 1 million by the company and 403,685 by selling shareholders.
The IPO raised $5.6 million in gross proceeds, including $4 million for the company and $1.6 million for selling shareholders.
The shares started trading on the Nasdaq Capital Market under the ticker symbol "HKPD" on Wednesday.
The company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 150,000 shares.
Hong Kong Pharma provides over-the-counter pharmaceutical cross-border e-commerce supply chain services in Hong Kong. It plans to use proceeds toward upgrading enterprise resource planning systems, acquiring warehouse equipment, expanding sales and marketing team, and general corporate needs.
Shares were up nearly 3% in recent trading.
Price: 2.90, Change: +0.08, Percent Change: +2.84
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.